Concepedia

Haefely We

HW

Statistics

Publications

4

Citations

246

H-Index

4

Active since

1982

Affiliations

Roche (Switzerland)(Current)

Haefely We is an author at Roche (Switzerland) specializing in pharmacology, monoamine pharmacology, and medicine.

Publications per year

1982–1990

4

Publications

4

On tyramine, food, beverages and the reversible MAO inhibitor moclobemide.

Da Prada M, G. Zürcher, I Wüthrich et al. · PubMed · 1988 · 175 citations

, , +17

Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors.

Da Prada M, R. Kettler, Keller Hh et al. · PubMed · 1989 · 33 citations

, , +13

Ro 19-6327, a reversible and highly selective monoamine, oxidase B inhibitor: a novel tool to explore the MAO-B function in humans.

Haefely We, R. Kettler, Keller Hh et al. · PubMed · 1990 · 26 citations

, , +10

Diclofensine (Ro 8-4650)--a potent inhibitor of monoamine uptake: biochemical and behavioural effects in comparison with nomifensine.

Keller Hh, R. Schaffner, Michele O. Carruba et al. · PubMed · 1982 · 12 citations

, , +8

1–4 of 4